Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-07-02 6:10 pm Purchase | 13G | Lumentum Holdings Inc. LITE | Point72 Asset Management L.P. | 3,382,398 5% | 3,382,398 (New Position) | View |
| 2024-06-24 4:51 pm Purchase | 13G | UroGen Pharma Ltd. URGN | Point72 Asset Management L.P. | 2,569,826 6.2% | 2,569,826 (New Position) | View |
| 2024-06-24 4:16 pm Purchase | 13G | Sphere Entertainment Co. SPHR | Point72 Asset Management L.P. | 1,560,170 5.5% | 1,560,170 (New Position) | View |
| 2024-06-14 4:34 pm Purchase | 13G | Olema Pharmaceuticals Inc. OLMA | Point72 Asset Management L.P. | 3,225,250 5.7% | 3,225,250 (New Position) | View |
| 2024-06-10 4:29 pm Purchase | 13G | MARAVAI LIFESCIENCES HOLDINGS INC. MRVI | Point72 Asset Management L.P. | 6,647,015 5% | 6,647,015 (New Position) | View |
| 2024-05-21 4:56 pm Purchase | 13G | Rapid7 Inc. RPD | Point72 Asset Management L.P. | 3,121,415 5% | 1,243,804 (+66.24%) | View |
| 2024-05-09 5:29 pm Purchase | 13G | Corvus Pharmaceuticals Inc. CRVS | Point72 Asset Management L.P. | 17,050,384 9.9% | 17,050,384 (New Position) | View |
| 2024-04-26 4:15 pm Purchase | 13G | Avid Bioservices Inc. CDMO | Point72 Asset Management L.P. | 3,226,006 5.1% | 3,226,006 (New Position) | View |
| 2024-04-05 4:05 pm Purchase | 13G | SUTRO BIOPHARMA INC. STRO | Point72 Asset Management L.P. | 5,932,908 7.9% | 5,932,908 (New Position) | View |
| 2024-03-26 4:21 pm Purchase | 13G | Fox Corp FOX | Point72 Asset Management L.P. | 12,046,118 5% | 12,046,118 (New Position) | View |
| 2024-03-25 4:33 pm Purchase | 13G | LENZ Therapeutics Inc. LENZ | Point72 Asset Management L.P. | 1,882,693 7.4% | 1,882,693 (New Position) | View |
| 2024-03-07 4:15 pm Purchase | 13G | Terns Pharmaceuticals Inc. TERN | Point72 Asset Management L.P. | 3,921,226 6.3% | 3,921,226 (New Position) | View |
| 2024-02-29 4:31 pm Purchase | 13G | Pulmonx Corp LUNG | Point72 Asset Management L.P. | 1,936,083 5% | 389,994 (+25.22%) | View |
| 2024-02-27 4:14 pm Purchase | 13G | Liberty Media Corp LLYVA | Point72 Asset Management L.P. | 1,287,149 5% | 1,287,149 (New Position) | View |
| 2024-02-23 4:28 pm Purchase | 13G | Ventyx Biosciences Inc. VTYX | Point72 Asset Management L.P. | 3,017,093 5.1% | 3,017,093 (New Position) | View |
| 2024-02-23 4:15 pm Purchase | 13G | CARIBOU BIOSCIENCES INC CRBU | Point72 Asset Management L.P. | 4,432,602 5% | 435,057 (+10.88%) | View |
| 2024-02-21 4:16 pm Purchase | 13G | AGENUS INC AGEN | Point72 Asset Management L.P. | 28,268,500 6.8% | 28,267,387 (+2539747.26%) | View |
| 2024-02-14 4:20 pm Purchase | 13G | ABEONA THERAPEUTICS INC. ABEO | Point72 Asset Management L.P. | 1,649,740 6.4% | 499,092 (+43.37%) | View |
| 2024-02-14 4:19 pm Purchase | 13G | PagSeguro Digital Ltd. PAGS | Point72 Asset Management L.P. | 10,933,610 5.6% | 231,012 (+2.16%) | View |
| 2024-02-14 4:18 pm Purchase | 13G | Lyra Therapeutics Inc. LYRA | Point72 Asset Management L.P. | 3,030,283 5.8% | 30,283 (+1.01%) | View |